Mr Paolo Sison | Director, Innovative Finance
Gavi, The Vaccine Alliance

Mr Paolo Sison, Director, Innovative Finance, Gavi, The Vaccine Alliance

Paolo Sison is Director of Innovative Finance at Gavi, the Vaccine Alliance. Gavi is a public-private partnership committed to saving lives and protecting people’s health by increasing access to immunisation in poor countries, and is a leading force in innovative finance for development. Gavi’s innovative finance mechanisms include the International Finance Facility for Immunisation (IFFIm), the Pneumococcal Advance Market Commitment and the Gavi Matching Fund.
Before joining Gavi, Paolo spent ten years in investment banking in London, most recently as Director, Global Banking and Markets at HSBC, where he was responsible for equity and equity-linked origination in the financial services sector across Western Europe and CEEMEA. His capital markets experience includes fixed income, hybrid and derivative origination and structuring. Previously, he spent six years in Manila and in Tokyo, with Ayala Corporation's Strategic Planning Group and with Mitsubishi Corporation's Development & Coordination Department. During this time he looked after the business groups’ investments in the financial services and industrial sectors, and was actively involved in business development in the Asia-Pacific region.
Paolo holds an MSc in Finance from London Business School and an MBA from the Asian Institute of Management.


Agenda Day 1 @ 11:40

Chair’s opening remarks

Agenda Day 1 @ 4:00

Innovative finance mechanisms for funding vaccine procurement

  • What financial mechanisms does GAVI use to ensure they can sustain investment in vaccines 
  • Tools used to incentivize certain types of vaccine development
    • E.g. Advanced market commitment to pneumococcal vaccines
  • The vaccine investment strategy process
    • Used to inform GAVI which vaccines they will invest in from 2020
    • GAVI’s view on the landscape of vaccine development

back to speakers